PPTA Welcomes New Executive Director of European Division
The Plasma Protein Therapeutics Association (PPTA) announced today that Maarten Van Baelen has joined the association as Executive Director, PPTA Europe. Maarten brings to PPTA more than 10 years in the life sciences arena, including as an advocate for access to generic, biosimilar and value-added medicines. He has represented the pharmaceutical sector’s interest in public forums, strategic policy development, and advocacy on key issues with the European Commission, National Competent Authorities, and other stakeholders.
Speaking of Van Baelen’s new role, PPTA President & CEO Amy Efantis said, “We are delighted that Maarten has joined the Association and we look forward to working with him as he leads our efforts in Europe. Maarten’s rich experience will allow him to represent the interests of the plasma protein therapy sector with patients, regulators, policymakers, and providers. He shares our commitment to ensuring our members are able to develop and provide therapies to the patients who need them.”
The Executive Director, PPTA Europe, is responsible for the management of health policy-related issues at the European and national levels, including programs and activities in support of PPTA’s global goals and objectives. He will serve as the senior point of contact for the plasma protein therapeutics industry in Europe to various governmental and non-governmental agencies and key European stakeholder groups, representing the Association’s positions and policies.
“I am very happy to join PPTA, especially at a time that promises significant changes in health care policy globally,” said Van Baelen. “Ensuring patient access to treatment has always been a priority to me. Securing access to plasma protein therapies, as well as encouraging individuals to donate plasma, is essential to ensuring people living with several rare and serious diseases can live healthy and normal lives, no matter where they live. It is an honour to be entrusted with such a responsibility.”
- Created on .